Analyze Diet

Detection of equine parvovirus-hepatitis and efficacy of governmental regulation for equine biologics purity.

Abstract: In 2018, a new virus, named equine parvovirus-hepatitis (EqPV-H), was discovered in a biologic product that had been administered to horses that subsequently developed clinical signs of equine serum hepatitis (Theiler disease). Further correlation of the virus with the disease sparked federal requirements that all equine biologics be free of EqPV-H. The initial quantitative real-time PCR (qPCR) test for EqPV-H has proved to be sensitive to co-extracted PCR inhibitors in template nucleic acids, causing false-negative results. We investigated the use of digital PCR (dPCR) as a more robust test. Examination of 227 equine biologic product lots available for purchase both before and after regulatory implementation using both detection methods indicated that dPCR is a more reliable platform. Nevertheless, use of the qPCR method for product screening had reduced the fraction of serials with EqPV-H detected from 39.6% prior to regulation to 6.8% after regulatory implementation. Adoption of dPCR testing is an opportunity to further decrease the prevalence of EqPV-H in equine biologics.
Publication Date: 2024-11-06 PubMed ID: 39506428PubMed Central: PMC11559848DOI: 10.1177/10406387241292343Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the discovery of a new virus in horses, equine parvovirus-hepatitis (EqPV-H), in 2018, and the subsequent regulatory requirements to ensure all equine biologics are free from EqPV-H. The study found that digital PCR (dPCR) is a more reliable detection method than quantitative real-time PCR (qPCR), despite qPCR being instrumental in reducing the infection rate from 39.6% to 6.8%.

Introduction to EqPV-H and Regulation

  • In 2018, a new virus was identified in horses, named equine parvovirus-hepatitis (EqPV-H).
  • This virus was discovered in biologic products administered to horses, following which the animals showcased signs of equine serum hepatitis, also known as Theiler disease.
  • This discovery instigated federal regulatory requirements to ensure all biologics used in horses were free of EqPV-H to prevent further spread of the disease.

Initial Testing Method

  • The first method of testing for EqPV-H was through a technique called quantitative real-time PCR (qPCR).
  • However, this method was susceptible to interference by co-extracted PCR inhibitors present in the nucleic acid samples.
  • These inhibitors could cause false-negative results, leading to an incorrect assessment of the sample’s EqPV-H status.

Investigation into Digital PCR

  • Digital PCR (dPCR) was investigated as an alternative, potentially more robust test for EqPV-H in equine biologics.
  • Researchers tested 227 lots of equine biologic products available both before and after the introduction of federal regulation, using both detection methods for comparison.
  • The study found that dPCR was a more reliable platform for the detection of EqPV-H than qPCR.

Reduction in EqPV-H and Future Directions

  • Despite the limitations in the qPCR method, its use in screening biologic products helped reduce the prevalence of EqPV-H in serials from 39.6% before regulation to 6.8% after regulation was implemented.
  • The adoption of dPCR testing in routine screening represents an opportunity to further decrease the prevalence of EqPV-H in equine biologics, strengthening the protection of horses against this virus.

Cite This Article

APA
Scupham AJ, Tong C. (2024). Detection of equine parvovirus-hepatitis and efficacy of governmental regulation for equine biologics purity. J Vet Diagn Invest, 37(1), 79-85. https://doi.org/10.1177/10406387241292343

Publication

ISSN: 1943-4936
NlmUniqueID: 9011490
Country: United States
Language: English
Volume: 37
Issue: 1
Pages: 79-85

Researcher Affiliations

Scupham, Alexandra J
  • Center for Veterinary Biologics, Animal and Plant Health Inspection Service, USDA, Ames, IA, USA.
Tong, Christopher
  • Center for Veterinary Biologics, Animal and Plant Health Inspection Service, USDA, Ames, IA, USA.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / virology
  • Horse Diseases / diagnosis
  • Biological Products / standards
  • Parvoviridae Infections / veterinary
  • Parvoviridae Infections / virology
  • Parvoviridae Infections / diagnosis
  • Parvovirus / isolation & purification
  • Real-Time Polymerase Chain Reaction / veterinary
  • Drug Contamination
  • Hepatitis, Viral, Animal / virology
  • Hepatitis, Viral, Animal / diagnosis

Conflict of Interest Statement

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

This article includes 34 references
  1. Baird J. The association of Equine Parvovirus-Hepatitis (EqPV-H) with cases of non-biologic-associated Theiler’s disease on a farm in Ontario, Canada. Vet Microbiol 2020;242:108575.
    pubmed: 32122586
  2. Conover WJ. Practical Nonparametric Statistics. 3rd ed. Wiley, 1999.
  3. Deprez L. Validation of a digital PCR method for quantification of DNA copy number concentrations by using a certified reference material. Biomol Detect Quantif 2016;9:29–39.
    pmc: PMC5007884pubmed: 27617230
  4. Dingle TC. Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances. Clin Chem 2013;59:1670–1672.
    pmc: PMC4247175pubmed: 24003063
  5. Divers TJ. New parvovirus associated with serum hepatitis in horses after inoculation of common biological product. Emerg Infect Dis 2018;24:303–310.
    pmc: PMC5782890pubmed: 29350162
  6. Dube S. Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS One 2008;3:e2876.
    pmc: PMC2483940pubmed: 18682853
  7. Gil-Farina I, Schmidt M. Interaction of vectors and parental viruses with the host genome. Curr Opin Virol 2016;21:35–40.
    pubmed: 27474966
  8. Hindson CM. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 2013;10:1003–1005.
    pmc: PMC4118677pubmed: 23995387
  9. Huggett JF, dMIQE Group. The digital MIQE guidelines update: minimum information for publication of quantitative digital PCR experiments for 2020. Clin Chem 2020;66:1012–1029.
    pubmed: 32746458
  10. Jacobs BKM. Model-based classification for digital PCR: your umbrella for rain. Anal Chem 2017;89:4461–4467.
    pubmed: 28350455
  11. Lievens A. Measuring digital PCR quality: performance parameters and their optimization. PLoS One 2016;11:e0153317.
    pmc: PMC4858304pubmed: 27149415
  12. Majumdar N. Digital PCR modeling for maximal sensitivity, dynamic range and measurement precision. PLoS One 2015;10:e0118833.
    pmc: PMC4373789pubmed: 25806524
  13. Mallows CL. Data description. In: Box GEP, et al.., eds. Scientific Inference, Data Analysis, and Robustness. Academic Press, 1983:135–151.
  14. Meister TL. Infection of young foals with Equine Parvovirus-Hepatitis following a fatal non-biologic case of Theiler’s disease. Vet Microbiol 2022;274:109557.
    pubmed: 36088712
  15. Meister TL. Characterization of equine parvovirus in thoroughbred breeding horses from Germany. Viruses 2019;11:965.
    pmc: PMC6833105pubmed: 31635426
  16. Meister TL. Equine parvovirus-hepatitis frequently detectable in commercial equine serum pools. Viruses 2019;11:461.
    pmc: PMC6563276pubmed: 31117220
  17. Opel KL. A study of PCR inhibition mechanisms using real time PCR. J Forensic Sci 2010;55:25–33.
    pubmed: 20015162
  18. Papapetrou MA. Prevalence of equine parvovirus-hepatitis in healthy broodmares in Ontario, Canada. Can J Vet Res 2023;87:169–175.
    pmc: PMC10291705pubmed: 37397641
  19. Ramsauer AS. Equine parvovirus hepatitis. Equine Vet J 2021;53:886–894.
    pmc: PMC8457058pubmed: 34101906
  20. Reinecke B. Clinical course of infection and cross-species detection of equine parvovirus-hepatitis. Viruses 2021;13:1454.
    pmc: PMC8402690pubmed: 34452320
  21. Rippke B. Center for Veterinary Biologics notice 19-03. New extraneous agent testing requirement for equine-origin antibody, antitoxin, serum, and plasma products regulated by APHIS. USDA-APHIS-VS, Center for Veterinary Biologicals, 2019.
  22. Rippke B. Center for Veterinary Biologics notice 20-08. Update to equine parvovirus extraneous agent testing requirement for equine-origin antibody, antitoxin, antivenin, serum, and plasma biological products regulated by APHIS. USDA-APHIS-VS, Center for Veterinary Biologicals, 2020.
  23. Ruijter JM. Efficiency correction is required for accurate quantitative PCR analysis and reporting. Clin Chem 2021;67:829–842.
    pubmed: 33890632
  24. Sidstedt M. Inhibition mechanisms of hemoglobin, immunoglobulin G, and whole blood in digital and real-time PCR. Anal Bioanal Chem 2018;410:2569–2583.
    pmc: PMC5857286pubmed: 29504082
  25. Theiler A. Acute liver-atrophy and parenchymatus hepatitis in horses. Report of the Director of Veterinary Research, Pretoria, South Africa 1918;5-6:9–164.
  26. Thermo Fisher Scientific. Real-time PCR: understanding Ct. 2016.
  27. Tomlinson JE. Tropism, pathology, and transmission of equine parvovirus-hepatitis. Emerg Microbes Infect 2020;9:651–663.
    pmc: PMC7144241pubmed: 32192415
  28. Tomlinson JE. Viral testing of 18 consecutive cases of equine serum hepatitis: a prospective study (2014–2018). J Vet Intern Med 2019;33:251–257.
    pmc: PMC6335536pubmed: 30520162
  29. Tomlinson JE. Viral testing of 10 cases of Theiler’s disease and 37 in-contact horses in the absence of equine biologic product administration: a prospective study (2014–2018). J Vet Intern Med 2019;33:258–265.
    pmc: PMC6335540pubmed: 30520132
  30. Tomlinson JE. What do we know about hepatitis viruses in horses?. Vet Clin North Am Equine Pract 2019;35:351–362.
    pubmed: 31084975
  31. Tomlinson JE, Van de Walle GR. Nasal transmission of equine parvovirus hepatitis. J Vet Intern Med 2022;36:2238–2244.
    pmc: PMC9708389pubmed: 36250682
  32. Toohey-Kurth K. Suggested guidelines for validation of real-time PCR assays in veterinary diagnostic laboratories. J Vet Diagn Invest 2020;32:802–814.
    pmc: PMC7649544pubmed: 32988335
  33. Vengust M. First report of equine parvovirus-hepatitis-associated Theiler’s disease in Europe. Equine Vet J 2020;52:841–847.
    pmc: PMC7483838pubmed: 32145096
  34. World Organisation for Animal Health (WOAH). Chapter 1.1.6. Validation of diagnostic assays for infectious diseases of terrestrial animals. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 13th ed. WOAH, 2024.